Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. daily Stock Chart
Amgen Inc.
IndexS&P 500 P/E15.95 EPS (ttm)12.88 Insider Own0.20% Shs Outstand599.77M Perf Week3.60%
Market Cap123.20B Forward P/E12.08 EPS next Y17.01 Insider Trans-2.43% Shs Float588.54M Perf Month-3.16%
Income7.84B PEG2.36 EPS next Q3.77 Inst Own80.40% Short Float1.48% Perf Quarter-13.86%
Sales23.36B P/S5.27 EPS this Y2.00% Inst Trans-0.08% Short Ratio2.67 Perf Half Y6.64%
Book/sh16.31 P/B12.59 EPS next Y8.53% ROA12.90% Target Price244.40 Perf Year6.80%
Cash/sh14.86 P/C13.83 EPS next 5Y6.75% ROE74.30% 52W Range166.30 - 244.99 Perf YTD-14.79%
Dividend6.40 P/FCF24.53 EPS past 5Y14.00% ROI21.20% 52W High-16.16% Beta0.89
Dividend %3.12% Quick Ratio1.20 Sales past 5Y3.10% Gross Margin81.40% 52W Low23.52% ATR12.38
Employees23400 Current Ratio1.40 Sales Q/Q-0.50% Oper. Margin41.40% RSI (14)50.27 Volatility4.49% 6.48%
OptionableYes Debt/Eq3.09 EPS Q/Q-5.20% Profit Margin33.60% Rel Volume0.69 Prev Close208.88
ShortableYes LT Debt/Eq2.79 EarningsApr 30 AMC Payout44.80% Avg Volume3.26M Price205.41
Recom2.20 SMA203.14% SMA50-3.12% SMA200-1.76% Volume2,263,892 Change-1.66%
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Apr-05-20 10:14AM  With gowns and masks in short supply, researchers test drugs to prevent COVID-19 infections in health care workers MarketWatch
Apr-03-20 06:58PM  Video: 4 Large-Cap Stocks With Strong Buffett-Munger Characteristics
10:51AM  Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In Zacks
Apr-02-20 07:58PM  Adaptive, Amgen collaborate on development of COVID-19 treatment American City Business Journals +5.60%
05:50PM  Covid Report: Amgen Pops As Heavyweight Biotech Enters Coronavirus Ring Investor's Business Daily
04:23PM  Biotech Amgen, Adaptive Tech Join Forces on New Coronavirus Drug SmarterAnalyst
03:43PM  Global Infections Top 1 Million; N.Y. Cases Rise: Virus Update Bloomberg
09:34AM  Amgen, Adaptive Biotechnologies ink COVID-19 antibody development collaboration MarketWatch
09:00AM  Amgen And Adaptive Biotechnologies Announce Strategic Partnership To Develop A Therapeutic To Prevent Or Treat COVID-19 PR Newswire
06:50AM  Amgen Stock Rises 3%
Mar-31-20 08:00PM  Amgen Establishes Wholly-Owned Affiliate In Japan PR Newswire
10:00AM  The Biggest Biotech Is Expected To Grow But Is It Enough To Be A Buy? Investor's Business Daily
05:47AM  Amgen Stock Falls 3%
Mar-30-20 01:06PM  Amgen Stock Looks to Break Out After Analyst Upgrade Investopedia +5.15%
Mar-28-20 10:00AM  Amgen Announces Positive Results At ACC.20/WCC From Phase 3B Study Of Repatha® (Evolocumab) In People Living With HIV Who Have High LDL-Cholesterol PR Newswire
Mar-27-20 11:04AM  Amgen Stock Rises 3%
10:27AM  Coronavirus Means Fewer Stock Buybacks, Analyst Says. It Could Shake Up Biopharma.
Mar-26-20 03:47PM  UnitedHealth Group rolls out coronavirus testing kits Yahoo Finance Video
07:38AM  Amgen Stock Rises 3%
Mar-25-20 04:06PM  Industries That Thrive During Recessions Investopedia
05:32AM  Amgen Stock Falls 3%
Mar-24-20 04:23PM  Biotech stocks have held up better than the broader market and these five are potential winners MarketWatch +8.83%
Mar-23-20 05:25PM  Amgen to donate up to $12.5M to COVID-19 relief efforts American City Business Journals
04:01PM  Amgen And The Amgen Foundation Commit Up To $12.5 Million To Support COVID-19 Relief Efforts PR Newswire
Mar-21-20 11:19AM  Market Experts Say the Coronavirus Selloff Is Worse Than Anything Weve Seen Since 1929. Heres How Bad It Could Get.
Mar-20-20 09:21AM  Amgen Stock Falls 4% -5.29%
Mar-19-20 09:20AM  Amgen Stock Falls 3%
Mar-18-20 06:35AM  Despite Its High P/E Ratio, Is Amgen Inc. (NASDAQ:AMGN) Still Undervalued? Simply Wall St.
Mar-17-20 07:02PM  5 Predictable Stocks Giving Markets a St. Patrick's Day Boost +10.13%
09:00AM  U.S. Should Buy Coronavirus Vaccines Before Theyre Invented Bloomberg
Mar-13-20 08:24PM  18 Stocks to Buy Amid the Coronavirus Carnage, According to Barrons Roundtable Experts +10.90%
02:25PM  Were effectively hitting the pause button on the economy: Financial Analyst Yahoo Finance Video
05:31AM  Amgen Stock Rises 5%
Mar-11-20 10:11PM  Hedge Funds Started Snapping Up Amgen, Inc. (AMGN) Too Early Insider Monkey
Mar-09-20 10:19AM  Is Amgen (AMGN) Truly One of the Best Biotech Stocks to Own? Zacks -5.83%
Mar-06-20 02:40PM  Stocks nosedive as coronavirus cases surpass 100K Yahoo Finance Video
04:33AM  Amgen Stock Falls 4%
Mar-05-20 02:47PM  Quest Diagnostics launching coronavirus test Yahoo Finance Video
11:05AM  3 Large Caps Announce Dividends
Mar-04-20 05:07PM  2 Undervalued-Predictable Health Care Stocks +5.23%
04:04PM  Amgen Announces 2020 Second Quarter Dividend PR Newswire
04:32AM  Amgen Stock Rises 3%
Mar-03-20 03:03PM  Inovio plans human trials of coronavirus vaccine in April Yahoo Finance Video
12:21PM  Amgen Stock Strength Climbs Amid 'New Product Driven' Growth Investor's Business Daily
08:21AM  Amgen Stock Falls 3%
Mar-02-20 02:34PM  Co-Diagnostics CEO on FDA's coronavirus policy changes Yahoo Finance Video +6.24%
06:56AM  Amgen Stock Rises 3%
Feb-29-20 11:31AM  Why Is Amgen (AMGN) Down 11.7% Since Last Earnings Report? Zacks
Feb-28-20 09:11AM  Amgen Stock Falls 4%
Feb-27-20 08:00PM  Amgen To Present At The Cowen 40th Annual Healthcare Conference PR Newswire -5.15%
06:11PM  Biohaven drug wins U.S. FDA approval for use in relieving migraine headaches Reuters
02:02PM  Biotech outlook amid race to develop coronavirus vaccine Yahoo Finance Video
12:33PM  IBD Rating Upgrades: Amgen Shows Improved Technical Strength Investor's Business Daily
09:10AM  Amgen Stock Falls 3%
05:45AM  New bill aims to protect medical product supply chain amid coronavirus outbreak Yahoo Finance
Feb-26-20 08:30AM  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis GlobeNewswire
08:30AM  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis PR Newswire
08:04AM  Amgen Stock Rises 3%
Feb-25-20 02:26PM  Berkshire Hathaway: No Urgency in the Urgent Zone
09:20AM  Amgen Stock Falls 3%
Feb-24-20 08:03AM  Amgen Stock Falls 3%
08:00AM  Drug pricing review group signs deal with Aetion for patient data Reuters
Feb-22-20 09:33AM  Would you tell your innermost secrets to Alexa? How AI therapists could save you time and money on mental health care MarketWatch
Feb-21-20 07:37PM  U.S. FDA approves Lundbeck's migraine prevention therapy Reuters
11:10AM  Pharmaceutical companies develop system to better track counterfeit drugs Reuters
Feb-20-20 11:42AM  Nations largest insurer invests in Waltham healthcare AI startup American City Business Journals
Feb-19-20 10:35AM  Revolution Medicines Joins Amgen and Mirati in Quest for New Type of Cancer Drugs
05:44AM  Bull of the Day: Guardant Health (GH) Zacks
Feb-18-20 10:49AM  Amgen Inc. -- Moody's assigns Baa1 rating to Amgen's new sr. unsecured notes; stable outlook Moody's
Feb-17-20 05:00AM  Buckingham's Bets in Biotech MoneyShow
Feb-14-20 09:02AM  Vertex Is the Top Big Biotech, According to Citi. 3 More Stocks It Says to Buy.
Feb-13-20 02:42PM  Leaner, More Agile Teva Sees Brighter Days Ahead
Feb-12-20 08:00PM  RPT-FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials Reuters
12:34PM  Coronavirus outbreak begins to disrupt booming China drug trials Reuters
12:27PM  FOCUS-Coronavirus outbreak begins to disrupt booming China drug trials Reuters
10:30AM  Buy AbbVie for its Growth Prospects, Yield and Low Valuation
Feb-11-20 05:27PM  Can Biotech ETFs Gain on Mixed Q4 Earnings Results? Zacks
09:15AM  J&J Files Application for Darzalex Label Expansion With FDA Zacks
06:14AM  If You Had Bought Amgen (NASDAQ:AMGN) Shares Five Years Ago You'd Have Made 47% Simply Wall St.
Feb-10-20 09:44AM  The Zacks Analyst Blog Highlights: Alphabet, Roche, Amgen, General Electric and Sony Zacks
Feb-07-20 02:45PM  Top Stock Research Reports for Alphabet, Roche & Amgen Zacks
10:49AM  Ligand (LGND) Q4 Earnings & Revenues Top Estimates, Stock Up Zacks
10:28AM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-06-20 03:45PM  Bristol-Myers' (BMY) Q4 Earnings & Revenues Beat Estimates Zacks
11:59AM  Amgen Stock Relative Strength Climbs Ahead Of Key Drug Data Investor's Business Daily
11:11AM  Sanofi (SNY) Q4 Earnings Top, Sales Miss, Dupixent Strong Zacks
08:29AM  Bristol-Myers Just Reported Earnings. Why Its Stock Is Jumping.
07:00AM  Survivors in Canada are Taking Steps to Reduce the Risk of Another Heart Attack. But is it Enough? CNW Group
Feb-05-20 09:04AM  Amgen Stock Rises 6%
Feb-04-20 02:32PM  Eaton Vance Exits Celgene, Trims Amgen Position
11:50AM  Teva's Two Pivotal Studies on Ajovy in Japan Meet Goal Zacks
10:22AM  Analysts Forecast Huge Upsides for Aimmune, Biohaven
09:03AM  Amgen Stock Rises 3%
Feb-01-20 03:01AM  Edited Transcript of AMGN earnings conference call or presentation 30-Jan-20 10:00pm GMT Thomson Reuters StreetEvents
Jan-31-20 04:41PM  How A Rumored Amgen Takeover Sent This Biotech Stock Flying Investor's Business Daily
01:22PM  Reata Pharma Soars on Amgen Takeover Rumor
12:40PM  The Dow Is Down 521 Points Because Coronavirus Isnt Going Away
11:39AM  Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential Benzinga
10:32AM  KB Home, National Beverage, Amazon, Visa and Amgen highlighted as Zacks Bull and Bear of the Day Zacks
10:07AM  Amgen Stock Falls 3%
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Piacquad DavidSVP, Business DevelopmentFeb 06Sale229.939,2642,130,07939,700Feb 07 08:25 PM
Williams R SandersDirectorFeb 06Sale233.7242599,3314,988Feb 10 09:33 PM
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM
SUGAR RONALD DDirectorMay 01Option Exercise54.712,000109,42015,092May 03 05:37 PM
SUGAR RONALD DDirectorMay 01Sale175.732,000351,46013,092May 03 05:37 PM